Invacare (NYSE:IVCRQ – Get Rating) and NanoVibronix (NASDAQ:NAOV – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings.
Volatility and Risk
Invacare has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, NanoVibronix has a beta of 0.9, meaning that its stock price is 10% less volatile than the S&P 500.
This table compares Invacare and NanoVibronix’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Institutional & Insider Ownership
59.9% of Invacare shares are owned by institutional investors. Comparatively, 5.3% of NanoVibronix shares are owned by institutional investors. 6.9% of Invacare shares are owned by insiders. Comparatively, 6.7% of NanoVibronix shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Earnings & Valuation
This table compares Invacare and NanoVibronix’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Invacare||$741.73 million||0.00||-$101.07 million||N/A||N/A|
NanoVibronix has lower revenue, but higher earnings than Invacare.
Invacare beats NanoVibronix on 6 of the 9 factors compared between the two stocks.
Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm’s products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Elmsford, NY.
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.